Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 14 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

29%

4 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (6)
P 2 (1)
P 3 (3)
P 4 (1)

Trial Status

Completed7
Recruiting4
Not Yet Recruiting2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 7 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT07854665Not ApplicableNot Yet RecruitingPrimary

A Randomized Controlled Clinical Trial of Transcutaneous Auricular Point Electrical Stimulation for Improving Symptoms of Chronic Tic Disorders in Children/Adolescents

NCT07839377Not ApplicableRecruitingPrimary

Teen and Adult Tic TMS Study

NCT07838428Not ApplicableNot Yet RecruitingPrimary

Let It TiC in Childhood Provisional Eye Tic

NCT06754319Recruiting

Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis

NCT06576726Recruiting

Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder

NCT06924918Not ApplicableEnrolling By InvitationPrimary

Scalp Acupuncture Treatment for Chronic Tic Disorders in Children

NCT06613126Not ApplicableRecruiting

Effectiveness of Symptom Management Application on Parental Care Ability of Children With Tourette Syndrome

NCT00755339CompletedPrimary

Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome

NCT01727713Phase 3Completed

Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

NCT00675675Not ApplicableCompletedPrimary

Neurocognitive Correlates of Behavioral Treatment for Childhood Tic Disorders

NCT01727700Phase 3Completed

Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

NCT01501695Phase 3CompletedPrimary

Phase III Study of 5LGr to Treat Tic Disorder

NCT00001658Phase 4Completed

Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections

NCT00001359Phase 2Completed

Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)

Showing all 14 trials

Research Network

Activity Timeline